1. Home
  2. BXMX vs VCEL Comparison

BXMX vs VCEL Comparison

Compare BXMX & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen S&P 500 Buy-Write Income Fund of Beneficial Interest

BXMX

Nuveen S&P 500 Buy-Write Income Fund of Beneficial Interest

HOLD

Current Price

$13.77

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$32.76

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BXMX
VCEL
Founded
2004
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
BXMX
VCEL
Price
$13.77
$32.76
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$58.50
AVG Volume (30 Days)
133.6K
487.7K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
7.24%
N/A
EPS Growth
N/A
60.00
EPS
N/A
0.32
Revenue
N/A
$276,259,000.00
Revenue This Year
N/A
$19.09
Revenue Next Year
N/A
$17.96
P/E Ratio
N/A
$100.88
Revenue Growth
N/A
16.45
52 Week Low
$11.25
$29.24
52 Week High
$15.00
$48.75

Technical Indicators

Market Signals
Indicator
BXMX
VCEL
Relative Strength Index (RSI) 34.45 38.81
Support Level $13.70 $31.34
Resistance Level $14.02 $38.15
Average True Range (ATR) 0.20 1.21
MACD -0.07 -0.15
Stochastic Oscillator 3.82 32.46

Price Performance

Historical Comparison
BXMX
VCEL

About BXMX Nuveen S&P 500 Buy-Write Income Fund of Beneficial Interest

Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options of writing index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: